Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos


The FDA cleared setmelanotide (Imcivree) for people age 6 and older with obesity due to a rare genetic

  • 1539985129686405120 Profile photo of Madelyn

    The FDA has approved a supplemental indication for setmelanotide injection for chronic weight management in adults and pediatric patients with obesity due to Bardet-Biedl Syndrome. https://t.co/3n1RCYMwCq - view on twitter